Live In Play®
Updated: 03-Sep-24 07:12 ET
ASH:  Ashland completes sale of nutraceuticals business to an affiliate of Turnspire Capital Partners, terms of deal not disclosed; Pharmachem Innovations, LLC announces its launch as independent company following the acquisition  (89.50)
  • Co announces that it has completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC effective August 30, 2024.
  • The sale includes custom formulation and contract manufacturing capabilities for the nutrition market from the production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico.
  • Financial terms of the transaction were not disclosed.
  • Additionally, Pharmachem Innovations, LLC, a provider of nutraceuticals products and solutions, announces its launch as an independent company, following the acquisition of the Company from Ashland by Turnspire Capital Partners LLC.
Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.
Send
Chat Icon